peoplePerson
Yuko Kitagawa
Yuko Kitagawa is a leading oesophageal surgeon in the JCOG network, whose trials define perioperative treatment for oesophageal cancer in Japan.
Yuko Kitagawa has led JCOG oesophageal cancer trials including JCOG1109 (NExT), which established triplet neoadjuvant chemotherapy for locally advanced oesophageal squamous cell carcinoma in Japan.
Role
Professor of Surgery, Keio University; oesophageal surgery; JCOG oesophageal group leadership
Institution
Specialisms
Oesophageal cancer surgeryPerioperative therapySentinel node navigation
Profiles
Pages like this
not linked directly; found by shared links- PersonHaruhiko Fukuda
Shares Japan Clinical Oncology Group (JCOG), Oesophageal cancer.
- InstitutionAichi Cancer Center
Shares Japan Clinical Oncology Group (JCOG), Oesophageal cancer.
- InstitutionOsaka International Cancer Institute
Shares Japan Clinical Oncology Group (JCOG), Oesophageal cancer.
- TrialCheckMate 577
Shares CROSS, Oesophageal cancer.
- InstitutionKyushu University Hospital
Shares Japan Clinical Oncology Group (JCOG), Oesophageal cancer.
- IdeaOrgan preservation as the default after complete response in oesophageal cancer
Shares CROSS, Oesophageal cancer.
- PairingCROSS chemoradiation → surgery → adjuvant nivolumab if residual disease
Shares CROSS, Oesophageal cancer.
- TermGastro-oesophageal junction (GEJ)
Shares CROSS, Oesophageal cancer.